Description :
Smart inhalers are clip-on sensors , also known as connected inhalers , which are attached to the traditional inhalers . They are used to track the medication , dosage , and time taken for each dose . Linked wirelessly to the cloud , smart inhalers are a part of “ Internet of Things ,” thus providing correct use of the medication , improved adherence to the inhaler , and better health outcomes . Doctors and patients can easily benefit from the use of smart inhalers as they monitor the dosage and provide reminders at the time of the dose , which can be recorded for understanding the patient ’ s daily routine .
Browse the full report @ http :// www . orbisresearch . com / reports / index / smart-inhalers-marketby-product-inhalers-and-nebulizers-dry-powder-inhalers-dpis-metered-dose-inhalers-mdisindication-asthma-and-copd-end-user-patients-and-r-and-d-global-opportunity-analysis-andindustry-forecast-2014-2022 .
The world smart inhalers market is analyzed under three different scenarios , namely , moderate growth , rapid growth , and diminishing growth . Under the moderate growth scenario , smart inhalers market is estimated to reach $ 191 million by 2022 , growing at a CAGR of 63.3 % during 2016 to 2022 . Market growth is attributed to the rapid increase in the incidence of respiratory diseases , rise in air pollution , and growth in healthcare burden , due to higher cases of asthma and COPD . In addition , expected increase in adherence to smart inhalers is another major factor for the growth of smart inhalers market . However , limited availability of smart inhalers , high cost of asthma and COPD treatment , and resistance towards adoption of smart inhalers are expected to hinder the market growth .
Check the DISCOUNT on this report @ http :// www . orbisresearch . com / contacts / discount / 223659 .
The market is segmented on the basis of product , indication , end user , and geography . By product , it is segmented into inhalers and nebulizers . Inhalers dominates the market , which is further divided into dry powder inhalers ( DPIs ) and metered dose inhalers ( MDIs ). Based on indication , smart inhalers are bifurcated into asthma and COPD . On the basis of end user , it is divided into patients and R & D . In terms of geography , the market is analyzed into North America , Europe , Asia-Pacific , and LAMEA .
North America was the leading revenue-generating region , whereas Asia-Pacific is projected to grow at the highest CAGR of 65.3 %, owing to rise in demand for smart inhalers and increase in COPD and asthma cases .
Companies have adopted product approval and clinical trials as their key development strategies . Increase in focus on clinical trials is mainly for the development of innovative technologies in the field of smart inhalers . In March 2016 , Adherium received a product approval to sell its “ SmartTurbo ” and “ SmartTouch ” devices in Canada , thereby expanding its product portfolio .
Purchase a copy of this report @ http :// www . orbisresearch . com / contact / purchase / 223659 .
2